The DOI matches its Crossref record; 79 of the 80 references it cites were found in a registry or an index, and 1 are not checked yet.
Genomics, Type 2 Diabetes, and Obesity
Open accessAbstract
The quickening pace of genetic discovery has resulted in the identification of more than 80 loci with proven roles in development of monogenic and multifactorial forms of nonautoimmune diabetes and obesity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The majority of associated loci are linked to beta cells, supporting the idea that impaired beta cell function is critical to type 2 diabetes pathogenesis78,80.”
From 100 years of insulin: celebrating the past, present and future of diabetes therapy (2021) · cites this paper as [80]
In the citing paper
“While a few loci are associated with obesity and insulin resistance, the vast majority are linked to the β-cell21.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [21]
Citations
Cites
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Self-citationGlobal and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Frayling, T. M., Timpson, N. J., Weedon, M. N., Zeggini, E., Freathy, R. M., Lindgren, C. M., Perry, J. R. B., Elliott, K. S., Lango, H., Rayner, N. W., et al. (2007) · Science · doi:10.1126/science.1141634 · Cited by 4,531
Self-citationA genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index
MAGIC, Speliotes, E. K., on behalf of Procardis Consortium, Willer, C. J., Berndt, S. I., Monda, K. L., Thorleifsson, G., Jackson, A. U., Allen, H. L., Lindgren, C. M., et al. (2010) · Nature Genetics · doi:10.1038/ng.686 · Cited by 2,912
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L., Erdos, M. R., Stringham, H. M., Chines, P. S., Jackson, A. U., et al. (2007) · Science · doi:10.1126/science.1142382 · Cited by 2,753
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287
Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes
Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H., Timpson, N. J., Perry, J. R. B., Rayner, N. W., Freathy, R. M., et al. (2007) · Science · doi:10.1126/science.1142364 · Cited by 2,194
Self-citationNew genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk
DIAGRAM Consortium, Dupuis, J., GIANT Consortium, Global BPgen Consortium, Anders Hamsten on behalf of Procardis Consortium, the MAGIC investigators, Langenberg, C., Prokopenko, I., Saxena, R., Soranzo, N., et al. (2010) · Nature Genetics · doi:10.1038/ng.520 · Cited by 2,166
Effects of Recombinant Leptin Therapy in a Child with Congenital Leptin Deficiency
Farooqi, I. S., Jebb, S. A., Langmack, G., Lawrence, E., Cheetham, C. H., Prentice, A. M., Hughes, I. A., McCamish, M. A., & O'Rahilly, S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411204 · Cited by 1,998
Wellcome Trust Case Control Consortium, Zeggini, E., Scott, L. J., Saxena, R., Voight, B. F., Marchini, J. L., Hu, T., de Bakker, P. I., Abecasis, G. R., Almgren, P., et al. (2008) · Nature Genetics · doi:10.1038/ng.120 · Cited by 1,864
Self-citationThe common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
Altshuler, D., Hirschhorn, J. N., Klannemark, M., Lindgren, C. M., Vohl, M.-C., Nemesh, J., Lane, C. R., Schaffner, S. F., Bolk, S., Brewer, C., et al. (2000) · Nature Genetics · doi:10.1038/79216 · Cited by 1,766
Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis
The MAGIC investigators, Voight, B. F., The GIANT Consortium, Scott, L. J., Steinthorsdottir, V., Morris, A. P., Dina, C., Welch, R. P., Zeggini, E., Huth, C., et al. (2010) · Nature Genetics · doi:10.1038/ng.609 · Cited by 1,761
Scuteri, A., Sanna, S., Chen, W.-M., Uda, M., Albai, G., Strait, J., Najjar, S., Nagaraja, R., Orrú, M., Usala, G., et al. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030115 · Cited by 1,724
the GIANT Consortium (2009) · Nature Genetics · doi:10.1038/ng.287 · Cited by 1,720
Self-citationVariation in FTO contributes to childhood obesity and severe adult obesity
Dina, C., Meyre, D., Gallina, S., Durand, E., Körner, A., Jacobson, P., Carlsson, L. M. S., Kiess, W., Vatin, V., Lecoeur, C., et al. (2007) · Nature Genetics · doi:10.1038/ng2048 · Cited by 1,619
Thorleifsson, G., Walters, G. B., Gudbjartsson, D. F., Steinthorsdottir, V., Sulem, P., Helgadottir, A., Styrkarsdottir, U., Gretarsdottir, S., Thorlacius, S., Jonsdottir, I., et al. (2009) · Nature Genetics · doi:10.1038/ng.274 · Cited by 1,375
Common variants at 30 loci contribute to polygenic dyslipidemia
Kathiresan, S., Willer, C. J., Peloso, G. M., Demissie, S., Musunuru, K., Schadt, E. E., Kaplan, L., Bennett, D., Li, Y., Tanaka, T., et al. (2009) · Nature Genetics · doi:10.1038/ng.291 · Cited by 1,364
Common variants near MC4R are associated with fat mass, weight and risk of obesity
The Prostate, L., Loos, R. J. F., KORA, Study, N. H., Initiative, D. G., Study, T. S., The Wellcome Trust Case Control Consortium, FUSION, Lindgren, C. M., Li, S., et al. (2008) · Nature Genetics · doi:10.1038/ng.140 · Cited by 1,325
Self-citationMyocardial Infarction Genetics Consortium (2009) · Nature Genetics · doi:10.1038/ng.327 · Cited by 1,088
A variant in CDKAL1 influences insulin response and risk of type 2 diabetes
Steinthorsdottir, V., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Jonsdottir, T., Walters, G. B., Styrkarsdottir, U., Gretarsdottir, S., Emilsson, V., Ghosh, S., et al. (2007) · Nature Genetics · doi:10.1038/ng2043 · Cited by 1,072
Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations
Pearson, E. R., Flechtner, I., Njølstad, P. R., Malecki, M. T., Flanagan, S. E., Larkin, B., Ashcroft, F. M., Klimes, I., Codner, E., Iotova, V., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061759 · Cited by 988
Inactivation of the Fto gene protects from obesity
Fischer, J., Koch, L., Emmerling, C., Vierkotten, J., Peters, T., Brüning, J. C., & Rüther, U. (2009) · Nature · doi:10.1038/nature07848 · Cited by 949
Clinical risk factors, DNA variants, and the development of type 2 diabetes
Lyssenko, V., Jonsson, A., Almgren, P., Pulizzi, N., Isomaa, B., Tuomi, T., Berglund, G., Altshuler, D., Nilsson, P., & Groop, L. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801869 · Cited by 938
MAGIC, Heid, I. M., Jackson, A. U., Randall, J. C., Winkler, T. W., Qi, L., Steinthorsdottir, V., Thorleifsson, G., Zillikens, M. C., Speliotes, E. K., et al. (2010) · Nature Genetics · doi:10.1038/ng.685 · Cited by 931
Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes
Lyssenko, V., Lupi, R., Marchetti, P., Del Guerra, S., Orho-Melander, M., Almgren, P., Sjögren, M., Ling, C., Eriksson, K.-F., Lethagen, Υ.-L., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30706 · Cited by 829
Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus
Yasuda, K., Miyake, K., Horikawa, Y., Hara, K., Osawa, H., Furuta, H., Hirota, Y., Mori, H., Jonsson, A., Sato, Y., et al. (2008) · Nature Genetics · doi:10.1038/ng.207 · Cited by 776
Altshuler, D., Daly, M., & Kruglyak, L. (2000) · Nature Genetics · doi:10.1038/79839 · Cited by 762
Gloyn, A. L., Weedon, M. N., Owen, K. R., Turner, M. J., Knight, B. A., Hitman, G., Walker, M., Levy, J. C., Sampson, M., Halford, S., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.2.568 · Cited by 754
Self-citationVariants in MTNR1B influence fasting glucose levels
Prokopenko, I., Langenberg, C., Florez, J. C., Saxena, R., Soranzo, N., Thorleifsson, G., Loos, R. J. F., Manning, A. K., Jackson, A. U., Aulchenko, Y., et al. (2009) · Nature Genetics · doi:10.1038/ng.290 · Cited by 744
Lyssenko, V., Nagorny, C. L. F., Erdos, M. R., Wierup, N., Jonsson, A., Spégel, P., Bugliani, M., Saxena, R., Fex, M., Pulizzi, N., et al. (2009) · Nature Genetics · doi:10.1038/ng.288 · Cited by 742
Unoki, H., Takahashi, A., Kawaguchi, T., Hara, K., Horikoshi, M., Andersen, G., Ng, D. P. K., Holmkvist, J., Borch-Johnsen, K., Jørgensen, T., et al. (2008) · Nature Genetics · doi:10.1038/ng.208 · Cited by 725
Gudmundsson, J., Sulem, P., Steinthorsdottir, V., Bergthorsson, J. T., Thorleifsson, G., Manolescu, A., Rafnar, T., Gudbjartsson, D., Agnarsson, B. A., Baker, A., et al. (2007) · Nature Genetics · doi:10.1038/ng2062 · Cited by 723
Hunter, D. J., Peltonen, L., Guiducci, C., Crawford, G., Hirschhorn, J. N., Lyon, H. N., & Speliotes, E. K. (2009) · DSpace@MIT (Massachusetts Institute of Technology) · Cited by 687
Meyre, D., Delplanque, J., Chèvre, J.-C., Lecoeur, C., Lobbens, S., Gallina, S., Durand, E., Vatin, V., Degraeve, F., Proença, C., et al. (2009) · Nature Genetics · doi:10.1038/ng.301 · Cited by 652
Self-citationBouatia-Naji, N., Bonnefond, A., Cavalcanti-Proença, C., Sparsø, T., Holmkvist, J., Marchand, M., Delplanque, J., Lobbens, S., Rocheleau, G., Durand, E., et al. (2009) · Nature Genetics · doi:10.1038/ng.277 · Cited by 611
Genetic cause of hyperglycaemia and response to treatment in diabetes
Pearson, E. R., Starkey, B. J., Powell, R. J., Gribble, F. M., Clark, P. M., & Hattersley, A. T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14571-0 · Cited by 607
A new highly penetrant form of obesity due to deletions on chromosome 16p11.2
Walters, R. G., Jacquemont, S., Valsesia, A., de Smith, A. J., Martinet, D., Andersson, J., Falchi, M., Chen, F., Andrieux, J., Lobbens, S., et al. (2010) · Nature · doi:10.1038/nature08727 · Cited by 543
Self-citationA map of open chromatin in human pancreatic islets
Gaulton, K. J., Nammo, T., Pasquali, L., Simon, J. M., Giresi, P. G., Fogarty, M. P., Panhuis, T. M., Mieczkowski, P., Secchi, A., Bosco, D., et al. (2010) · Nature Genetics · doi:10.1038/ng.530 · Cited by 541
Clinical implications of a molecular genetic classification of monogenic β-cell diabetes
Murphy, R., Ellard, S., & Hattersley, A. T. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0778 · Cited by 502
Common genetic variation near MC4R is associated with waist circumference and insulin resistance
Chambers, J. C., Elliott, P., Zabaneh, D., Zhang, W., Li, Y., Froguel, P., Balding, D., Scott, J., & Kooner, J. S. (2008) · Nature Genetics · doi:10.1038/ng.156 · Cited by 497
Rung, J., Cauchi, S., Albrechtsen, A., Shen, L., Rocheleau, G., Cavalcanti-Proença, C., Bacot, F., Balkau, B., Belisle, A., Borch-Johnsen, K., et al. (2009) · Nature Genetics · doi:10.1038/ng.443 · Cited by 479
What makes a good genetic association study?
Hattersley, A. T., & McCarthy, M. I. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67531-9 · Cited by 470
Self-citationBoissel, S., Reish, O., Proulx, K., Kawagoe-Takaki, H., Sedgwick, B., Yeo, G. S. H., Meyre, D., Golzio, C., Molinari, F., Kadhom, N., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.06.002 · Cited by 396
Common variants in WFS1 confer risk of type 2 diabetes
Sandhu, M. S., Weedon, M. N., Fawcett, K. A., Wasson, J., Debenham, S. L., Daly, A., Lango, H., Frayling, T. M., Neumann, R. J., Sherva, R., et al. (2007) · Nature Genetics · doi:10.1038/ng2067 · Cited by 381
Self-citationTsai, F.-J., Yang, C.-F., Chen, C.-C., Chuang, L.-M., Lu, C.-H., Chang, C.-T., Wang, T.-Y., Chen, R.-H., Shiu, C.-F., Liu, Y.-M., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000847 · Cited by 346
Scherag, A., Dina, C., Hinney, A., Vatin, V., Scherag, S., Vogel, C. I. G., Müller, T. D., Grallert, H., Wichmann, H.-E., Balkau, B., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000916 · Cited by 327
Self-citationHuman genetics illuminates the paths to metabolic disease
O’Rahilly, S. (2009) · Nature · doi:10.1038/nature08532 · Cited by 324
A Mouse Model for the Metabolic Effects of the Human Fat Mass and Obesity Associated FTO Gene
Church, C., Lee, S., Bagg, E. A. L., McTaggart, J. S., Deacon, R., Gerken, T., Lee, A., Moir, L., Mecinović, J., Quwailid, M. M., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000599 · Cited by 324
Regulation of Fto/Ftm gene expression in mice and humans
Stratigopoulos, G., Padilla, S. L., LeDuc, C. A., Watson, E., Hattersley, A. T., McCarthy, M. I., Zeltser, L. M., Chung, W. K., & Leibel, R. L. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00839.2007 · Cited by 324
Self-citationFreathy, R. M., Timpson, N. J., Lawlor, D. A., Pouta, A., Ben-Shlomo, Y., Ruokonen, A., Ebrahim, S., Shields, B., Zeggini, E., Weedon, M. N., et al. (2008) · Diabetes · doi:10.2337/db07-1466 · Cited by 316
Self-citationGenome-based prediction of common diseases: advances and prospects
Janssens, A. C. J. W., & van Duijn, C. M. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn250 · Cited by 314
Orho-Melander, M., Melander, O., Guiducci, C., Perez-Martinez, P., Corella, D., Roos, C., Tewhey, R., Rieder, M. J., Hall, J., Abecasis, G., et al. (2008) · Diabetes · doi:10.2337/db08-0516 · Cited by 301
Common nonsynonymous variants in PCSK1 confer risk of obesity
Benzinou, M., Creemers, J. W. M., Choquet, H., Lobbens, S., Dina, C., Durand, E., Guerardel, A., Boutin, P., Jouret, B., Heude, B., et al. (2008) · Nature Genetics · doi:10.1038/ng.177 · Cited by 300
Lango, H., the U.K. Type 2 Diabetes Genetics Consortium, Palmer, C. N. A., Morris, A. D., Zeggini, E., Hattersley, A. T., McCarthy, M. I., Frayling, T. M., & Weedon, M. N. (2008) · Diabetes · doi:10.2337/db08-0504 · Cited by 294
Self-citationFlorez, J. C. (2008) · Diabetologia · doi:10.1007/s00125-008-1025-9 · Cited by 293
Variation in TCF7L2 Influences Therapeutic Response to Sulfonylureas
Pearson, E. R., Donnelly, L. A., Kimber, C., Whitley, A., Doney, A. S. F., McCarthy, M. I., Hattersley, A. T., Morris, A. D., & Palmer, C. N. A. (2007) · Diabetes · doi:10.2337/db07-0440 · Cited by 286
Self-citationHeard-Costa, N. L., Zillikens, M. C., Monda, K. L., Johansson, Å., Harris, T. B., Fu, M., Haritunians, T., Feitosa, M. F., Aspelund, T., Eiriksdottir, G., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000539 · Cited by 282
Predicting Type 2 Diabetes Based on Polymorphisms From Genome-Wide Association Studies
van Hoek, M., Dehghan, A., Witteman, J. C. M., van Duijn, C. M., Uitterlinden, A. G., Oostra, B. A., Hofman, A., Sijbrands, E. J. G., & Janssens, A. C. J. W. (2008) · Diabetes · doi:10.2337/db08-0425 · Cited by 280
Rafiq, M., Flanagan, S. E., Patch, A.-M., Shields, B. M., Ellard, S., Hattersley, A. T., & The Neonatal Diabetes International Collaborative Group (2008) · Diabetes Care · doi:10.2337/dc07-1785 · Cited by 265
Type 2 diabetes: new genes, new understanding
Prokopenko, I., McCarthy, M. I., & Lindgren, C. M. (2008) · Trends in Genetics · doi:10.1016/j.tig.2008.09.004 · Cited by 254
Self-citationCornelis, M. C., Qi, L., Zhang, C., Kraft, P., Manson, J., Cai, T., Hunter, D. J., & Hu, F. B. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-8-200904210-00008 · Cited by 230
Life cycle of translational research for medical interventions
Contopoulos-Ioannidis, D. G., Alexiou, G. A., Gouvias, T. C., & Ioannidis, J. P. A. (2008) · Science · doi:10.1126/science.1160622 · Cited by 207
Winckler, W., Weedon, M. N., Graham, R. R., McCarroll, S. A., Purcell, S., Almgren, P., Tuomi, T., Gaudet, D., Boström, K. B., Walker, M., et al. (2007) · Diabetes · doi:10.2337/db06-0202 · Cited by 203
Self-citationVaxillaire, M., Cavalcanti-Proença, C., Dechaume, A., Tichet, J., Marre, M., Balkau, B., Froguel, P., & for the DESIR Study Group (2008) · Diabetes · doi:10.2337/db07-1807 · Cited by 191
Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes
Qi, L., Cornelis, M. C., Kraft, P., Stanya, K. J., Linda Kao, W. H., Pankow, J. S., Dupuis, J., Florez, J. C., Fox, C. S., Paré, G., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq156 · Cited by 191
Larsen, L. H., Echwald, S. M., Sørensen, T. I. A., Andersen, T., Wulff, B. S., & Pedersen, O. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0497 · Cited by 176
Lindgren, C. M., Heid, I. M., Randall, J. C., Lamina, C., Steinthorsdottir, V., Qi, L., Speliotes, E. K., Thorleifsson, G., Willer, C. J., Herrera, B. M., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000508 · Cited by 170
Timpson, N. J., Lindgren, C. M., Weedon, M. N., Randall, J. C., Ouwehand, W. H., Strachan, D. P., Rayner, N. W., Walker, M., Hitman, G. A., Doney, A. S. F., et al. (2008) · Diabetes · doi:10.2337/db08-0906 · Cited by 129
Self-citationType 2 diabetes: pathogenesis and treatment
Stümvoll, M., Goldstein, B. J., & van Haeften, T. W. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60932-0 · Cited by 127
Sample size determination for studies of gene-environment interaction
Luan, J., Wong, M., Day, N., & Wareham, N. (2001) · International Journal of Epidemiology · doi:10.1093/ije/30.5.1035 · Cited by 123
Growing evidence for diabetes susceptibility genes from genome scan data
McCarthy, M. I. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0040-y · Cited by 120
Self-citationOwen, K. R., Thanabalasingham, G., James, T. J., Karpe, F., Farmer, A. A., McCarthy, M. I., & Gloyn, A. L. (2010) · Diabetes Care · doi:10.2337/dc10-0288 · Cited by 119
Self-citationFranks, P. W., Rolandsson, O., Debenham, S. L., Fawcett, K. A., Payne, F., Dina, C., Froguel, P., Mohlke, K. L., Willer, C. J., Olsson, T., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0887-6 · Cited by 115
Prevalence of Loss-of-Function FTO Mutations in Lean and Obese Individuals
Meyre, D., Proulx, K., Kawagoe-Takaki, H., Vatin, V., Gutiérrez‐Aguilar, R., Lyon, D., Ma, M. K. L., Choquet, H., Horber, F., Hul, W. V., et al. (2009) · Diabetes · doi:10.2337/db09-0703 · Cited by 107
Evaluation of risk prediction updates from commercial genome-wide scans
Mihăescu, R., van Hoek, M., Sijbrands, E. J. G., Uitterlinden, A. G., Witteman, J. C. M., Albert Hofman, D., van Duijn, C. M., & Janssens, A. C. J. W. (2009) · Genetics in Medicine · doi:10.1097/gim.0b013e3181b13a4f · Cited by 77
Establishing the role of gene-environment interactions in the etiology of type 2 diabetes
Wareham, N. J., Franks, P. W., & Harding, A.-H. (2002) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(02)00007-5 · Cited by 34
Pearson, E. R. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0028-3 · Cited by 31
Waterfield, T., & Gloyn, A. L. (2008) · Pediatric Health · doi:10.2217/17455111.2.4.517 · Cited by 18
Cited by
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
Zheng, Y., Ley, S. H., & Hu, F. B. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.151 · Cited by 5,697
Pathophysiology of type 2 diabetes mellitus
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176275 · Cited by 3,360
“Over the past decade, several T2DM genome-wide association studies have shown the complex polygenic nature of T2DM in which most of these loci increase T2DM risk through primary effects on insulin secretion, and a minority act through reducing insulin action [21,22].”
BackgroundInflammation, metaflammation and immunometabolic disorders
Hotamisligil, G. S. (2017) · Nature · doi:10.1038/nature21363 · Cited by 2,570
Visscher, P. M., Brown, M. A., McCarthy, M. I., & Yang, J. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.11.029 · Cited by 2,425
Self-citationThe worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives
Chen, L., Magliano, D. J., & Zimmet, P. Z. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.183 · Cited by 2,227
Metadata
- Authors
- McCarthy, M. I.
- Affiliations
- Centre for Human Genetics (GB)
- Corresponding author
- McCarthy, Mark I.
- ORCID
- McCarthy, Mark I.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-12-09
- Volume
- 363
- Issue
- 24
- Pages
- 2339-2350
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2019020805
- Cited by
- 938
- References
- 79
- Citations by year
- 2026: 21 · 2025: 14 · 2024: 24 · 2023: 32 · 2022: 38 · 2021: 48 · 2020: 43 · 2019: 46 · 2018: 46 · 2017: 51 · 2016: 70 · 2015: 77 · 2014: 98 · 2013: 122 · 2012: 123
- FWCI
- 11.17
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Mapping and Diversity in Plants and Animals
- Keywords
- type 2 diabetes, obesity, genetic loci, genetic susceptibility, monogenic diabetes, genetic discovery
- MeSH terms
- Diabetes Mellitus, Type 2, Diagnosis, Differential, Humans, Obesity, Genetic Variation, Body Mass Index, Genetic Predisposition to Disease, Genome-Wide Association Study, Genetic Loci, Translational Research, Biomedical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.